Scinai Immunotherapeutics (SCNI) Current Assets (2017 - 2025)

Scinai Immunotherapeutics has disclosed Current Assets across 9 years of filings, most recently posting $2.1 million for Q4 2025.

• Current Assets for Q4 2025 came in at $2.1 million, down 14.09% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.1 million (down 14.09% YoY), and the FY2025 annual result was $2.1 million, down 14.09% from the prior year.
• Current Assets came in at $2.1 million for Q4 2025 at Scinai Immunotherapeutics, up from $1.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $17.8 million in Q4 2021 to a low of $1.5 million in Q2 2025.
• The 5-year median for Current Assets is $6.7 million (2023), against an average of $7.4 million.
• Across the five-year window, Current Assets surged 439.88% in 2021 and plunged 75.91% in 2024, its largest moves.
• Scinai Immunotherapeutics' Current Assets stood at $17.8 million in 2021, then slipped by 19.46% to $14.4 million in 2022, then slumped by 62.09% to $5.4 million in 2023, then slumped by 56.1% to $2.4 million in 2024, then declined by 14.09% to $2.1 million in 2025.
• The last three Current Assets figures came in at $2.1 million (Q4 2025), $1.5 million (Q2 2025), and $2.4 million (Q4 2024), per Business Quant data.